» Articles » PMID: 20180858

Towards a Brucella Vaccine for Humans

Overview
Specialty Microbiology
Date 2010 Feb 26
PMID 20180858
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

There is currently no licensed vaccine for brucellosis in humans. Available animal vaccines may cause disease and are considered unsuitable for use in humans. However, the causative pathogen, Brucella, is among the most common causes of laboratory-acquired infections and is a Center for Disease Control category B select agent. Thus, human vaccines for brucellosis are required. This review highlights the considerations that are needed in the journey to develop a human vaccine, including animal models, and includes an assessment of the current status of novel vaccine candidates.

Citing Articles

A Thermosensitive and Degradable Chitin-Based Hydrogel as a Brucellosis Vaccine Adjuvant.

Ju R, Lu Y, Jiang Z, Chi J, Wang S, Liu W Polymers (Basel). 2024; 16(19).

PMID: 39408526 PMC: 11478596. DOI: 10.3390/polym16192815.


Current Challenges of Vaccination in Fish Health Management.

Kumar A, Middha S, Menon S, Paital B, Gokarn S, Nelli M Animals (Basel). 2024; 14(18).

PMID: 39335281 PMC: 11429256. DOI: 10.3390/ani14182692.


Proteomics Exploration of to Design an Innovative Multi-Epitope mRNA Vaccine.

Asadinezhad M, Pakzad I, Asadollahi P, Ghafourian S, Kalani B Bioinform Biol Insights. 2024; 18:11779322241272404.

PMID: 39220468 PMC: 11365029. DOI: 10.1177/11779322241272404.


Development of a novel multi-epitope vaccine for brucellosis prevention.

Shang K, Zhu Y, Tian T, Shi H, Yin Z, He Y Heliyon. 2024; 10(14):e34721.

PMID: 39148966 PMC: 11325379. DOI: 10.1016/j.heliyon.2024.e34721.


Investigation of the Seroprevalence of Brucella Antibodies and Characterization of Field Strains in Immunized Dairy Cows by A19.

Shi Y, Cui Y, Wudong G, Li S, Yuan Y, Zhao D Vet Sci. 2024; 11(7).

PMID: 39057972 PMC: 11281660. DOI: 10.3390/vetsci11070288.